BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 27583853)

  • 1. Influence of the first radioactive iodine ablation on peripheral complete blood count in patients with differentiated thyroid cancer.
    Hu T; Meng Z; Zhang G; Jia Q; Tan J; Zheng W; Wang R; Li X; Liu N; Zhou P; Upadhyaya A
    Medicine (Baltimore); 2016 Aug; 95(35):e4451. PubMed ID: 27583853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mild decreases in white blood cell and platelet counts are present one year after radioactive iodine remnant ablation.
    Molinaro E; Leboeuf R; Shue B; Martorella AJ; Fleisher M; Larson S; Tuttle RM
    Thyroid; 2009 Oct; 19(10):1035-41. PubMed ID: 19772430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term bone marrow suppression in differentiated thyroid cancer patients after radioactive iodine treatment.
    Yi W; Kim BH; Kim M; Ryang SR; Jang MH; Kim JM; Kim EH; Jeon YK; Kim SS; Kim IJ
    Endocr J; 2020 Dec; 67(12):1193-1198. PubMed ID: 32727965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ¹³¹I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer.
    Rui Z; Wu R; Zheng W; Wang X; Meng Z; Tan J
    Med Sci Monit; 2021 Feb; 27():e929590. PubMed ID: 33568620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin Attenuates 131I-Induced Decrease in Peripheral Blood Cells in Patients with Differentiated Thyroid Cancer.
    Bikas A; Van Nostrand D; Jensen K; Desale S; Mete M; Patel A; Wartofsky L; Vasko V; Burman KD
    Thyroid; 2016 Feb; 26(2):280-6. PubMed ID: 26649977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complete blood counts are frequently abnormal 1 year after dosimetry-guided radioactive iodine therapy for metastatic thyroid cancer.
    Padovani RP; Tuttle RM; Grewal R; Larson SM; Boucai L
    Endocr Pract; 2014 Mar; 20(3):213-20. PubMed ID: 24126230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison between the different doses of radioactive iodine ablation prescribed in patients with intermediate-to-high-risk differentiated thyroid cancer.
    Iizuka Y; Katagiri T; Ogura K; Mizowaki T
    Ann Nucl Med; 2019 Jul; 33(7):495-501. PubMed ID: 30955202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal Analysis of the Effect of Radioiodine Therapy on Ovarian Reserve in Females with Differentiated Thyroid Cancer.
    van Velsen EFS; Visser WE; van den Berg SAA; Kam BLR; van Ginhoven TM; Massolt ET; Peeters RP
    Thyroid; 2020 Apr; 30(4):580-587. PubMed ID: 31928168
    [No Abstract]   [Full Text] [Related]  

  • 9. Temporary changes in neutrophil-to-lymphocyte, platelet-to-lymphocyte ratios, and mean platelet volume reflecting the inflammatory process after radioiodine therapy.
    Demir Y; Üçler R; Sürücü E; Turan M; Balli Z; Şengöz T
    Nucl Med Commun; 2016 Apr; 37(4):393-8. PubMed ID: 26619396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of radioactive iodine therapy on liver function in patients with differentiated thyroid cancer.
    Wang S; Liang C; Zhao L; Meng Z; Zhang C; Jia Q; Tan J; Yang H; Liu X; Wang X
    Nucl Med Commun; 2018 Dec; 39(12):1113-1120. PubMed ID: 30247387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiated Thyroid Cancer lymph-node relapse. Role of adjuvant radioactive iodine therapy after lymphadenectomy.
    Piccardo A; Puntoni M; Bottoni G; Treglia G; Foppiani L; Bertoli M; Catrambone U; Arlandini A; Dib B; Altrinetti V; Massollo M; Bossert I; Cabria M; Bertagna F; Giovanella L
    Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):926-934. PubMed ID: 27966046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of 131I therapy on peripheral blood in children and adolescents with differentiated thyroid carcinoma].
    Wang J; Zhao W; Liu B; Kuang A
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2011 Dec; 28(6):1185-8. PubMed ID: 22295711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-surgical thyroid ablation with low or high radioiodine activities results in similar outcomes in intermediate risk differentiated thyroid cancer patients.
    Castagna MG; Cevenini G; Theodoropoulou A; Maino F; Memmo S; Claudia C; Belardini V; Brianzoni E; Pacini F
    Eur J Endocrinol; 2013 Jul; 169(1):23-9. PubMed ID: 23594687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timing of Radioactive Iodine Administration Does Not Influence Outcomes in Patients with Differentiated Thyroid Carcinoma.
    Scheffel RS; Zanella AB; Dora JM; Maia AL
    Thyroid; 2016 Nov; 26(11):1623-1629. PubMed ID: 27549175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapse-free survival after adjuvant radioactive iodine therapy in patients with differentiated thyroid carcinoma with a microscopically positive tumor margin.
    Watanabe K; Igarashi T; Uchiyama M; Ojiri H
    Ann Nucl Med; 2020 Dec; 34(12):920-925. PubMed ID: 32940889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-Dose RAI Therapy Justified by Pathological N1a Disease Revealed by Prophylactic Central Neck Dissection for cN0 Papillary Thyroid Cancer Patients: Is it Superior to Low-Dose RAI Therapy?
    Wei L; Bai L; Zhao L; Yu T; Ma Q; Ji B
    World J Surg; 2019 May; 43(5):1256-1263. PubMed ID: 30684002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone-Marrow Suppression in Elderly Patients Following Empiric Radioiodine Therapy: Real-Life Data.
    Duskin-Bitan H; Leibner A; Amitai O; Diker-Cohen T; Hirsch D; Benbassat C; Shimon I; Robenshtok E
    Thyroid; 2019 May; 29(5):683-691. PubMed ID: 31084551
    [No Abstract]   [Full Text] [Related]  

  • 18. Transient early increase in thyroglobulin levels post-radioiodine ablation in patients with differentiated thyroid cancer.
    Stevic I; Dembinski TC; Pathak KA; Leslie WD
    Clin Biochem; 2015 Jul; 48(10-11):658-61. PubMed ID: 25895485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is radioactive iodine- 131 treatment related to the occurrence of non-synchronous second primary malignancy in patients with differentiated thyroid cancer?
    Souza MC; Momesso DP; Vaisman F; Vieira Neto L; Martins RA; Corbo R; Vaisman M
    Arch Endocrinol Metab; 2016 Feb; 60(1):9-15. PubMed ID: 26222230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of radioiodine therapy on blood cell count in patients with differentiated thyroid cancer.
    Demir AN; Kara Z; Sulu C; Uysal S; Zulfaliyeva G; Atar OA; Valikhanova N; Ozturk T; Ozkaya HM; Damci T; Gonen MS
    Hormones (Athens); 2023 Dec; 22(4):595-602. PubMed ID: 37603221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.